Upgrade to Pro
— share decks privately, control downloads, hide ads and more …
Speaker Deck
Sign up for free
Menu
Search
Features
All features
Private URLs
Password Protection
Custom URLS
Scheduled publishing
Remove Branding
Restrict embedding
Deck Collections
Notes
Features
All features
Private URLs
Password Protection
Custom URLS
Scheduled publishing
Remove Branding
Restrict embedding
Deck Collections
Notes
Explore
Featured decks
Featured speakers
Programming
Technology
Storyboards
Explore
Featured decks
Featured speakers
Programming
Technology
Storyboards
Pricing
Search
Sign in
Sign up for free
PharmaX White paper
Search
PharmaX
September 12, 2022
Technology
14k
0
Share
Embed
Copy iframe code
Copy JS code
Copy link
Start on current slide
PharmaX White paper
PharmaX
September 12, 2022
More Decks by PharmaX
See All by PharmaX
YOJO Brand Book
pharma_x
0
3.7k
PharmaX Company Deck for Engineers
pharma_x
2
2.2k
PharmaX Company Deck
pharma_x
1
44k
Other Decks in Technology
See All in Technology
リアーキテクチャ後の障害ゼロを目指したShadow Testingの取り組み
nihonbuson
PRO
1
180
Kiro Meetup #8 Kiro アップデート (2026/3/21〜2026/9/24)
katzueno
1
220
「大丈夫そう?」をObservabilityで確かめる
mrmtsu
0
150
人にやさしく、AIにやさしく、書き手を選ばないIaCのガードレール再考 / Rethinking IaC Guardrails for Humans and AI Alike
kohbis
5
1k
品質と信頼性を地続きにする
grimoh
2
1k
Oracle Cloud Infrastructure(OCI):Onboarding Session(はじめてのOCI/Oracle Supportご利⽤ガイド)
oracle4engineer
PRO
2
20k
2026-09-18 gotanda.sre Terraformで複数環境作ったり、複数Stateに分割したりそれとTerragrunt / Terraform multi envs and multi states
masasuzu
4
730
Argo CDとAtlantisで実現するインフラ管理のセルフサービス化──小規模SREチームで支えるプラットフォーム
cassius7
0
110
AIに賢く動いてもらうためのコンテキスト〜Snowflake女子会 vol.8
snowwmn0824
0
180
AIエージェントの権限管理 3: Agentic RAG の Fine grained access control 編
ren8k
1
260
ADKで始める業務改善 - AIエージェント開発時の考えと設計
harappa80
2
290
フルカイテン株式会社 エンジニア向け採用資料
fullkaiten
0
12k
Featured
See All Featured
Done Done
chrislema
187
17k
Agile that works and the tools we love
rasmusluckow
331
22k
We Analyzed 250 Million AI Search Results: Here's What I Found
joshbly
1
2k
Applied NLP in the Age of Generative AI
inesmontani
PRO
4
2.5k
The Psychology of Web Performance [Beyond Tellerrand 2023]
tammyeverts
49
3.6k
Measuring & Analyzing Core Web Vitals
bluesmoon
9
1k
Visualization
eitanlees
153
17k
Claude Code どこまでも/ Claude Code Everywhere
nwiizo
67
58k
I Don’t Have Time: Getting Over the Fear to Launch Your Podcast
jcasabona
35
2.8k
4 Signs Your Business is Dying
shpigford
187
23k
Crafting Experiences
bethany
1
350
Designing for Performance
lara
611
70k
Transcript
͔͔Γ͚ͭༀہΛ࣮ݱ͢Δ ༀہDXͱϦϞʔτༀࡎࢣ σʔλ͔Βඥղ͘ɺϦϞʔτༀࡎࢣͷظͱల
ʢCʣPharmaX Inc. 2022 All Rights Reserve 2 ࣍ ۀքಈ ༀہDXͷ࣮ଶͱ՝
ϦϞʔτༀࡎࢣͷՄೳੑ PharmaXͷऔΈ ͍͞͝ʹ P.03-05 P.06-12 P.13-15 P.16-22 P.23-25
ʢCʣPharmaX Inc. 2022 All Rights Reserve 3 ۀքಈ ༀہΛऔΓר͘େ͖ͳมԽ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 4 ۀքಈɹༀہΛऔΓר͘େ͖ͳมԽ ۙɺༀہΛऔΓר͘େ͖ͳมԽ͕ى͖͍ͯΔ มԽͷϙΠϯτʮༀہͷσδλϧ׆༻ʯͱʮༀࡎࢣͷಇ͖ํվֵʯ
ΦϯϥΠϯༀࢦಋͷ߃ٱԽϦϞʔτༀࡎࢣͷղېɺిࢠॲํͤΜಋೖɺௐࡎͷ֎෦ҕୗʹؔ͢Δݕ౼ ͳͲɺༀہΛऔΓר͘େ͖ͳมԽ͕͜ͷͰى͖͍ͯΔɻ ΦϯϥΠϯༀࢦಋ ిࢠॲํͤΜʢ20231݄ࢪߦ༧ఆʣ ௐࡎͷ֎෦ҕୗʢݕ౼தʣ ΦϯϥΠϯྍ ిΦϯϥΠϯͰͷༀͷઆ໌͕Մೳʹ ▶ױऀ͞·ༀہʹग़͔ͣɺࣗʹ͍ͳ͕ΒༀΛड͚औΔ͜ͱ͕Ͱ͖Δ ిΦϯϥΠϯͰͷྍ͕Մೳʹ ▶ױऀ͞·පӃʹग़͔ͣɺࣗʹ͍ͳ͕ΒྍΛड͚Δ͜ͱ͕Ͱ͖Δ ϦϞʔτༀࡎࢣʢ2022ࢪߦ༧ఆʣ ༀࡎࢣͷࡏۈ͕Մೳʹ ▶ༀࡎࢣ͕ༀࢦಋΛߦ͏ॴͷཧత੍͕ղআ͞ΕΔ ࢴͷॲํͤΜͷిࢠԽ͕Մೳʹ ▶ࢴͷॲํͤΜͷཧతΓͱΓ͕ͳ͘ͳΔ ϦϑΟϧॲํͤΜʢ20224݄ࢪߦʣ 1ຕͷॲํͤΜͰɺͳ্͘ݶͰ͘Γ͔͓͑͠ༀͷॲํ͕Մೳʹ ▶ॲํͤΜΛΒ͏ͨΊ͚ͩͷ͕ݮΔ ͜Ε·Ͱༀہ͝ͱʹߦ͍ͬͯͨରۀͷཧతू͕Մೳʹ ▶ରۀͷޮԽʹΑΓɺରਓॆͯΔ͕࣌ؒ૿͑Δ 1 2 3 4 5 6
ʢCʣPharmaX Inc. 2022 All Rights Reserve 5 ۀքಈɹༀہΛऔΓר͘େ͖ͳมԽ ҩྍͷ࣭ҩྍΞΫηε্ͷͨΊʮ͔͔Γ͚ͭༀہʯͷస͕ٸ ɾॲํͤΜड࣌Ҏ֎ͷରਓۀॆ࣮
ɾௐࡎޙͷϑΥϩʔΞοϓଟࡎ༻ͷରԠ ɾηϧϑϝσΟέʔγϣϯͷࢧԉͷ݈߁αϙʔτ ʮ͔͔Γ͚ͭༀہʯͷ࣮ݱʹDX͕ඞਢ ͜Ε͔Βͷ࣌ ʮͲͷҩྍػؔΛडͯ͠ɺༀہ͔͔Γ͚ͭʯ ௐࡎޙͷϑΥϩʔΞοϓଟࡎ༻ͷରԠ͚ͩͰͳ͘ɺηϧϑέΞɾηϧϑϝσΟέʔγϣϯࢧԉͷ݈ ߁αϙʔτۀͷॆ࣮ٻΊΒΕ͍ͯΔɻ ظ͞ΕΔରਓۀͷ͞ΒͳΔॆ࣮ Ҭแׅ έΞ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 6 ༀہDXͷ࣮ଶͱ՝ ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX
ʢCʣPharmaX Inc. 2022 All Rights Reserve 7 ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX ͔͔Γ͚ͭػೳ࣮ݱʹରਓۀͷॆ࣮ʹ͚ͨରۀͷޮԽ͕ඞཁ ͜Ε·Ͱͷༀࡎࢣͷۀͷத৺ରۀͰ͕͋ͬͨɺςΫϊϩδʔΛ׆༻ͨ͠ରۀͷޮԽΛߦ
͍ɺༀࡎࢣͷରਓۀΛॆ࣮͍ͤͯ͘͜͞ͱ͕ٻΊΒΕ͍ͯΔɻ ޮԽ ମݧͷ্ DX ɾॲํ༰ͷνΣοΫ ɾஸೡͳༀࢦಋ ɾΞϑλʔϑΥϩʔ ɾ݈߁αϙʔτ ɾҩࢣͷٙٛরձͷ࿈ܞ ରਓۀ ରۀ ɾॲํͤΜཧ ɾૹۀ ɾࡏݿཧ ɾใुࢉఆ ɾༀࡎަ ɾௐࡎ ɾༀࡎࠪ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 8 ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX ରۀͷDXࣄྫ ௐࡎϓϩηεʹϩϘοτΛ׆༻͢Δ͜ͱͰରۀΛޮԽ͢Δༀہొɻ·ͨɺௐࡎͷ֎෦ҕୗʹͭ
͍ͯ҆શੑ୲อͷॴࡏͳͲͷͱڞʹ͕ٞ։࢝͞Ε͍ͯΔɻ ϩϘοτௐࡎ ॲํσʔλΛೖྗ͢Δ͜ͱͰɺༀͷϐοΩϯά͔Βṝྔɺׂɺ แ·ͰΛϩϘοτ͕ߦ͏͜ͱɻۀͷޮԽͱ͍͏ҙຯ߹͍͚ͩ Ͱͳ͘ɺਓҝతͳϛεΛ͙ͱ͍͏ׂظ͞Ε͍ͯΔɻ ը૾Πϝʔδ ௐࡎͷ֎෦ҕୗ ※ݕ౼த ॲํͤΜΛड͚औͬͨༀہ͕ɺผͷༀہʹௐࡎۀΛҕୗ͢Δ͜ͱɻ தখༀہͳͲ͕ҕୗʹΑͬͯରਓۀΛΑΓڧԽ͍͚ͯ͠Δͱظ ͞ΕΔɻ2022ΑΓް࿑লʹͯݕ౼͕։࢝͞Ε͕ͨɺ҆શੑͷ୲อ ͷॴࡏͳͲͷ͕ଟ͘ɺ৻ॏʹٞ͞Ε͍ͯΔɻ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 9 ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX ରਓۀΛࢧԉ͢ΔDXࣄྫ ରਓۀͷॆ࣮ͷͨΊʹɺױऀ͞·ͷঢ়گѲΛԁʹͨ͠ΓɺༀہͰͷใ࿈ܞΛࢧԉͨ͠Γ͢ΔIT
πʔϧ͕ొɻ༷ʑͳػೳΛूͤͯ͞ༀࡎࢣͷۀޮԽΛࢧԉ͢Δπʔϧଟ͍ɻ ిࢠༀྺπʔϧ ΦϯϥΠϯༀࢦಋπʔϧ ϏσΦ௨ػೳʹΑΓΦϯϥΠϯͰױऀ͞·ͱༀࢦಋ͕Ͱ͖Δͩ ͚Ͱͳ͘ɺॲํͤΜͷΦϯϥΠϯडΩϟογϡϨεܾࡁɺళฮ ཧͳͲ༷ʑͳपลػೳࡌɻΦϯϥΠϯྍͱڞʹఏڙ͢Δا ۀଟ͘ɺΫϦχοΫͱͷ࿈ܞՄೳʹɻ ༀہͷϨηίϯͱ࿈ಈ͠ɺױऀ͞·ͷॲํྺ෭࡞༻ྺɺༀࢦಋ ༰ͳͲΛهɾཧ͢ΔγεςϜɻΫϥυܕͰར༻͘͢͠ ͳͬͨΓɺༀࢦಋΛ͠ͳ͕ΒༀྺΛهͰ͖ͨΓɺༀࡎࢣͷۀ ޮΛߴΊΔπʔϧ͕ొ͍ͯ͠Δɻ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 10 ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX ”ༀہDX”ਐΉͷͷɺ͔͔Γ͚ͭༀہͷ࣮ݱʹ՝͕ Q.ҎԼͷ࣮ࢪසΛڭ͍͑ͯͩ͘͞
Q.ༀہʹDXπʔϧΛಋೖ͍ͯ͠·͔͢ʁ ग़యɿPharmaXʮༀہۀʹؔ͢Δௐࠪʯ20228݄ ɾΦϯϥΠϯༀࢦಋ πʔϧ༁ ɾిࢠϨηίϯ ɾిࢠༀྺ ɾίϛϡχέʔγϣ ϯɹɹπʔϧ ༀہDXπʔϧಋೖ ͔͔Γ͚ͭͷ࣮ଶ ͍ 95% ৗతͳίϛϡχέʔγϣϯ ݈߁αϙʔτ(පؾͷ༧ͳͲ) ༀࢦಋͷ࣌ؒ 80%ͷༀہͰ 5ະຬ 70%ͷༀہͰ Θ͔ͣͳױऀ͞·ͷΈ࣮ࢪ 75%ͷༀہͰ Θ͔ͣͳױऀ͞·ͷΈ࣮ࢪ ΦϯϥΠϯༀࢦಋ 75%ͷༀہͰ 5%ҎԼͷ࣮ࢪ ͍͍͑ 5% ΄ͱΜͲͷༀہͰITπʔϧͷ׆༻͕ਐΜͰ͍ΔͷͷɺༀࢦಋΞϑλʔϑΥϩʔɺࠒͷ݈߁αϙʔτ ͳͲɺ͔͔Γ͚ͭػೳʹ՝ҙࣝΛ࣋ͭༀہ͕ଟ͍ɻ ɹ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 11 ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX πʔϧΛಋೖ͢Δ͚ͩͰৗʹ͓͚Δ·Ͱख͕ճΒͳ͍࣮ଶ ITπʔϧΛಋೖͨ͠ͷͷɺैདྷͷۀʹՃ͑ͯৗతͳίϛϡχέʔγϣϯ݈߁αϙʔτ·Ͱख͕ճΒ
ͳ͍ɻༀࡎࢣ͕গͳ͍ༀہͰͦͷ͕ݦஶͳҰํɺ૿һ͢Δ͜ͱݱ࣮తͰͳ͍ɻ ग़యɿPharmaXʮༀہۀʹؔ͢Δௐࠪʯ20228݄ ैདྷܕͷༀہͰༀࡎࢣΛ૿һ͢Δ͜ͱʹ ݱ࣮తͳ͕͋͠͞Δ Q.ϑΥϩʔΞοϓͷͨΊͷ ૿һݕ౼Λ͍ͯ͠·͔͢ʁ ૿һ༧ఆ͕͋Δ 15% ૿һ༧ఆ͕ͳ͍/ ͍͕ͨ͠Ͱ͖ͳ͍ 85% Q.ళฮ͋ͨΓͷ ༀࡎࢣ ༀࡎࢣ͕গͳ͍ༀہ΄Ͳױऀ͞·ͷ ʮ͔͔Γ͚ͭʯΛेʹ࣮ࢪͰ͖ͯͳ͍՝ҙࣝ Q.ༀ͔Β࣍ճདྷہ·Ͱ ίϛϡχέʔγϣϯΛ ױऀ͞·ͱͱΕ͍ͯ·͔͢ʁ Q.ױऀ͞·ͷ ݈߁αϙʔτ ࣮ࢪͰ͖͍ͯ·͔͢ʁ 4໊ҎԼ 70% 5ਓҎ্ʹൺ4ਓະຬͷ߹ͷ࣮ࢪׂ߹ 1/2 38% ױऀ͞·Ҏ্ʹͱΕ͍ͯΔ ױऀ͞·Ҏ্ʹͰ͖͍ͯΔ 20% 14% 30% 5໊Ҏ্ 4໊ҎԼ 5໊Ҏ্ 4໊ҎԼ ༀࡎࢣ ༀࡎࢣ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 12 ͔͔Γ͚ͭػೳͷ࣮ݱʹॊೈͳༀࡎࢣਓࡐͷ׆༻͕ඞਢɻༀہ֎͔ΒΦϯϥΠϯༀࢦಋ͢ΔɺॴҦʮϦϞʔ τༀࡎࢣʯ͕ɺैདྷͷಇ͖ํͰۈͰ͖ͳ͘ͳͬͨજࡏༀࡎࢣͷ׆༻ΛՄೳʹ͢Δɻ ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX
ༀࡎࢣਓࡐͷॊೈͳ׆༻͕͔͔Γ͚ͭػೳ࣮ݱͷՄೳੑΛߴΊΔ ҩༀɺҩྍػثͷ࣭ɺ༗ޮੑٴͼ ҆શੑͷ֬อʹؔ͢Δ๏ࢪߦنଇͷվਖ਼ જࡏༀࡎࢣ9ສਓ ͜Ε·Ͱɺࢪߦنଇୈ 15ͷ13ୈ߲̎ͷنఆʹج͖ͮɺༀࡎ ࢣ͕ΦϯϥΠϯༀࢦಋΛߦ͏߹ɺༀہ։ઃऀ֘ༀࡎ ࢣʹରͯ͠ɺༀࢦಋΛߦ͏ઃඋ͕͋Δༀہͷॴʹ͓͍ͯ ߦΘͤΔ͜ͱͱ͞Ε͍͕ͯͨɺ֘ༀہʹ͓͍ͯௐࡎʹैࣄ ͢Δༀࡎࢣͱ૬ޓʹ࿈བྷΛͱΔ͜ͱ͕Ͱ͖Δॴʹ͓͍ͯߦΘ ͤΔ͜ͱՄೳͱ͢Δɻ ʮϦϞʔτༀࡎࢣʯͷղې 2022 9݄ࢪߦ ༀࡎࢣࢿ֨Λ͍࣋ͬͯͳ͕Β৬ʹब͍͍ͯͳ͍ํ (ްੜ࿑ಇলྩୈඦࡾेࣣ߸ΑΓ)
ʢCʣPharmaX Inc. 2022 All Rights Reserve 13 ϦϞʔτༀࡎࢣͷՄೳੑ ϦϞʔτༀࡎࢣͷ׆༻͕ΩʔϙΠϯτ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 14 ϦϞʔτༀࡎࢣͷՄೳੑɹϦϞʔτༀࡎࢣͷ׆༻͕ΩʔϙΠϯτ ༀہ֎͔ΒԕִͰಇ͘ʮϦϞʔτༀࡎࢣʯͱ͍͏ಇ͖ํ ϦϞʔτༀࡎࢣͷಇ͖ํ
ϦϞʔτ ༀࡎࢣ ױऀ͞· ༀࢦಋͳͲ͕Մೳʹ ΦϯϥΠϯ௨πʔϧΛ༻͍ͯༀہ֎͔ΒԕִͰༀࡎࢣۀΛߦ͏ༀࡎࢣͷ͜ͱɻҭࣇհޢͷࣄ Ͱɺࢿ֨Λ࣋ͬͨ··ༀࡎࢣͱͯ͠ಇ͚͍ͯͳ͍ਓࡐͷ׆༻ΛՄೳʹ͢Δɻ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 15 ϦϞʔτༀࡎࢣͷՄೳੑɹϦϞʔτༀࡎࢣͷ׆༻͕ΩʔϙΠϯτ ϦϞʔτༀࡎࢣͱ͍͏ಇ͖ํͷظେ͖͍ ैདྷͷಇ͖ํͰༀہͰͷۈΛલఏͱ͍ͯͨͨ͠Ίɺ৷ग़࢈ɺҭࣇɺհޢͳͲͷࣄʹΑΓༀࡎ
ࢣͱͯ͠ಇ͘͜ͱΛఘΊΔέʔε͕ҰఆଘࡏɻϦϞʔτༀࡎࢣͰ͋ΕࡏͰͷಇ͖ํ͕࣮ݱՄೳɻ Q.ୀ৬࣌ͷཧ༝Λڭ͍͑ͯͩ͘͞ ͍ 62% Q.ൺֱతࣗ༝ʹ͕࣌ؒ͑ΔΑ͏ʹͳΕ ಇ͖ଓ͚ΒΕΔͱࢥ͍·͔͢ʁ ɾࢠͲͷૹΓܴ͑ͳͲɺ͔ࣗ͠Δਓ͕͍ͳ͍ͨΊ ɾ͜Ε·Ͱग़ۈ͕ଟ͘Ոͱͷ͕࣌ؒ࣋ͯͳ͔ͬͨ Q.ϦϞʔτϫʔΫͰಇ͍ͯΈ͍ͨͱࢥ͍·͔͢ ͍ 66% ɾ݈߁্ͷཧ༝͔Βಇ͘͜ͱ͕͘͠ͳͬͨ 13% ɾΩϟϦΞεςοϓ͕Ίͳ͔ͬͨ 13% ɾ৽͍͠ࣄʹνϟϨϯδͯ͠Έ͔ͨͬͨ 14% ༀہΛΊΔཧ༝ ϦϞʔτϫʔΫͷظ ৷ɾग़࢈ɾҭࣇɾհޢͱ ཱ྆Ͱ͖ͳ͘ͳͬͨ 40% ৬Ͱͷਓؒؔʹෆຬ͕ ͋ͬͨ 31% څ༩ʹෆຬ͕͋ͬͨ 29% ͍͍͑18% ͔Βͳ͍ 20% ͍͍͑34% ग़యɿPharmaXʮༀہༀࡎࢣͷ৬ܦݧʹؔ͢Δௐࠪʯʮༀہۀʹؔ͢Δௐࠪʯ20228݄
ʢCʣPharmaX Inc. 2022 All Rights Reserve 16 PharmaXͷऔΈ ϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 17 PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ ༀࡎࢣLINEͰ͍ͭͰ૬ஊͰ͖ΔOTCํͷECαʔϏεʮYOJOʯ ಠࣗͷΈͰ
ϦϞʔτༀࡎࢣΛ׆༻ 2019ΑΓༀࡎࢣLINEͰ͍ͭͰ૬ஊͰ͖ΔOTCํͷECαʔϏεʮYOJOʯΛఏڙɻར༻ऀͷ͔͔ Γ͚ͭ૬ஊΛ࣮ݱ͢ΔͨΊʹɺಠࣗͷΈΛ༻͍ͯϦϞʔτༀࡎࢣΛ׆༻ɻ ༀࡎࢣʹ૬ஊͰ͖Δ OTCํͷECαʔϏε ϦϞʔτༀࡎࢣ͕νϟοτԼॻ͖Λ࡞͠ɺళฮͷༀࡎࢣ͕ૹ৴͢ΔΈΛ ߏஙɻͷอ݈ॴ୲ऀΑΓ๏९क͍ͯ͠ΔࢫͷճΛ͍͍ͯΔɻಛڐ ٕज़ʢ*ಛڐ7029836ʣɻ ױऀ͞· ༀࡎࢣ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 18 Q.ϦϞʔτༀࡎࢣͱͯ͠ಇ͍ͯ Α͔ͬͨ͜ͱʁ PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ
20໊ͷༀࡎࢣ͕ϦϞʔτༀࡎࢣͱͯ͠׆༂͠ɺಇ͖͢͞Λ࣮ײ ҎલҰൠతͳༀہʹۈ͍ͯͨ͠ༀࡎࢣ͕ɺϦϞʔτༀࡎࢣʹͳΔ͜ͱͰॊೈͳಇ͖ํΛ࣮ݱɻ Ոఉͱࣄͷཱ͚྆ͩͰͳ͘ɺༀࡎࢣͱͯ͠ͷͷͨΊͷ࣌ؒࢿ͕Մೳʹɻ ॴͷ੍ݶ͕ͳ͍ ɾٸͳͷసۈ͕͋ͬͨͱͯ͠స৬Λߟ͑ͳͯ͘ࡁΜͩ ͕࣌ؒॊೈʹͳͬͨɺՈͱͷ࣌ؒ ͕૿͑ͨ ɾࢠͲͷٸͳମௐෆྑߦࣄɺश͍ࣄͳͲॊೈʹରԠͰ͖Δ ɾೖ͔ࣾͯ͠Β͜Ͳ͕ੜ·Εɺ࠺ͷαϙʔτ͜ͲͷΛɹ ɹݟΔ͕࣌ؒͱΕΔ ࣗݾݚᮎͷ͕࣌ؒ૿͑ͨ ɾ௨ۈ͕࣌ؒͳ͍ͨΊɺேबۀޙͷ࣌ؒΛ׆༻ͯ͠ษڧ͕ ɹͰ͖Δ ॴͷ੍ݶ͕ ͳ͘ͳͬͨ ۈ͕࣌ؒॊೈ ʹͰ͖ΔΑ͏ʹ ͳͬͨɾՈͱ ͷ͕࣌ؒ૿͑ͨ ࣗݾݚᮎͷͨΊ ͷ͕࣌ؒ૿͑ͨ ਓؒؔͷΈ ͕ͳ͘ͳΓಇ͖ ͘͢ͳͬͨ ͦͷଞ 50% 93% 93% 43% 7% ग़యɿPharmaXʮϦϞʔτༀࡎࢣͷಇ͖ํʹؔ͢Δௐࠪʯ20228݄
ʢCʣPharmaX Inc. 2022 All Rights Reserve 19 PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ [ࢀߟ] ࣌ؒॴʹनΘΕͳ͍ϦϞʔτༀࡎࢣͱ͍͏ಇ͖ํ
ϦϞʔτۈʹΑͬͯ࣌ؒॴʹनΘΕͳ͍͜ͱͰɺༀہۈͰ͍͠ࣄͱՈఉͷཱ͕྆Մೳʹɻ ετϨεΛײͣ͡ɺࣗ༝ʹಇ͘͜ͱ͕Ͱ͖͍ͯΔɻ ࣌ؒॴʹनΘΕͣಇ͘͜ͱ͕ Ͱ͖ΔΑ͏ʹͳΓɺಇ͖͘͢ͳΓ·ͨ͠ɻ Ҏલͷ৬͔ࣗΒԕ͘ɺࢠͲͷૹΓܴ͑Λߟ͑Δͱޕޙ͔ Β͔͠ಇ͘͜ͱ͕Ͱ͖ͣༀࡎࢣͱͯ͠ࣄΛଓ͚Δͷ͕ݫ͍͠ͳ ͱײ͍ͯͨ͡ͱ͜ΖɺʮϦϞʔτༀࡎࢣʯͱ͍͏ଘࡏΛΓ·͠ ͨɻࠓͰ͏·ۭ͍ͨ࣌ؒ͘Λ͍ͳ͕Βɺಇ͘͜ͱ͕Ͱ͖͍ͯ ·͢ɻ 5:30 23:00 9:00 ۈ ४උ ୀۈ ͜ͲͨͪΛݟૹΔ ଉࢠͷ॓ΛݟΔɾՈࣄ εʔύʔۜߦ ່ͷؼΛग़ܴ͑ʙ 18:00 YOJOༀࡎࢣA͞Μͷ1 ௨ۈ͕ ෆཁʂ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 20 PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ ༀࡎࢣΩϟϦΞΛ֦ு͢Δબࢶͱͯ͠ͷʮϦϞʔτༀࡎࢣʯ Q.ϦϞʔτༀࡎࢣͱͯ͠
ༀࡎࢣࢿ֨Λ׆͔ͯ͠ಇ͖ଓ͚͍ͨͰ͔͢ʁ ϦϞʔτༀࡎࢣͱ͍͏ಇ͖ํༀࡎࢣਓࡐͷՁΛ͞Βʹ׆͔͢͜ͱʹܨ͕Δɻશࠃʹଘࡏ͢Δજࡏༀ ࡎࢣ׆༻ʹΑΓɺҩྍΞΫηεͷ্ͱҩྍͷ࣭ʹߩݙͰ͖ΔͷͰͳ͍͔ɻ ϦϞʔτͰ ಇ͖ଓ͚͍ͨ 86% ͲͪΒͰΑ͍ɺ Θ͔Βͳ͍ 14% ग़యɿPharmaXʮϦϞʔτༀࡎࢣͷಇ͖ํʹؔ͢Δௐࠪʯ20228݄
ʢCʣPharmaX Inc. 2022 All Rights Reserve 21 PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ ॊೈͳಇ͖ํༀࡎࢣ͕ױऀ͞·ͱ͖߹͍͍͢ڥ࣮ݱ ಇ͖͍͢ڥʹΑΓༀࡎࢣ͕৺ͷ༨༟Λ࣋ͬͯಇ͘͜ͱ͕Ͱ͖ɺױऀ͞·ʹΑΓ͖߹͍͘͢ͳΔɻ
ϦϞʔτͰױऀ͞·ͱରԠ͢Δ͜ͱ͕Ͱ͖Δ͜ͱͰɺױऀ͞·ରԠ ͢ΔༀࡎࢣࣗͷॅΈ׳ΕͨՈɺϦϥοΫεͰ͖ΔڥͰର͢Δ ͜ͱ͕Ͱ͖ΔͨΊ͓ޓ͍ʹ͍͢͠ͱࢥ͏ɻ ༀࡎࢣױऀ͞·ϦϥοΫε Ͱ͖ΔڥͰର͕Ͱ͖Δ ཧతڑ͋ͬͯྑ͍ؔΛ ங͘͜ͱ͕Ͱ͖Δͷ͕ັྗత ױऀ͞·ͱཧతڑ͋ͬͯɺױऀ͞·ͷΈʹدΓఴ͑ͨΓɺ ମௐͷมԽΛتΔؔੑͱͯັྗతͩͱࢥ͏ɻ ௨ৗͷༀہͰ༷ʑͳ੍ݶͰɺରԠͰ͖ͳ͍ױऀ͞·ͷΈঢ়ʹ ରԠͰ͖Δɻ·ͨॅΜͰ͍ΔॴʹؔΘΒͣɺױऀ͞·ͷ૬ஊʹରԠ ͢Δ͜ͱ͕Ͱ͖Δɻ ௨ৗͷༀہͰରԠͰ͖ͳ͍ ΈʹରԠͰ͖Δ ࡏͰಇ͚Δ͜ͱͰ༨༟Λͬ ͨಇ͖ํ͕Ͱ͖͍ͯΔ ϦϞʔτମ੍͕͍ࡏͰಇ͚Δ͜ͱͰɺ৬ͷมͳؾݣ͍ετ Ϩε͕ܰݮ͠ɺ༨༟Λ࣋ͬͨಇ͖ํ͕Ͱ͖͍ͯΔɻ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 22 PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ ϦϞʔτༀࡎࢣͷ׆༻͕࣮ݱ͢Δ͔͔Γ͚ͭػೳ ॊೈͳༀࡎࢣͷ׆༻ʹΑΓɺৗͰͷܧଓతͳαϙʔτ͕ՄೳʹɻༀࡎࢣͷʹΑͬͯױऀ͞·ͷຬ
͕ߴ·Γɺ݈߁ҙࣝͷ্ʹد༩Ͱ͖ΔͷͰͳ͍͔ɻ ϦϞʔτༀࡎࢣͷ׆༻͔͔Γ͚ͭༀہ࣮ݱͷҰख 90ˋ ૬ஊ͢͠͞ʹຬ͍ͯ͠Δ YOJOͷױऀ͞· පӃͰ͋·ΓΛฉ͍ͯ͘Εͳ͔ͬͨΓɺ৺Ҽతͳͷ ͱͯ͠·ͱΊΒΕͯ͠·ͬͨΓͱɺෆ҆ࠓޙͲ͏͍ͯ͠ ͚͍͍ͷ͔Α͘Θ͔Βͳ͘ͳͬͯ͠·ͬͨͱ͖ɺༀࡎࢣ ͞Μ͕ʹͳͬͯߟ͑ͯͩͬͨ͘͞ʂ डͰ͋Ε࣌ؒΛݟܭΒ͏ ͜ͱ͕ඞཁ͚ͩΕͲɺLINEͰ ͋Εࣗͷ伱ؒ࣌ؒʹ࣭ ͤͯ͞Β͑Δ ૬ஊ͍ͨ͠ࣄΛϦΞϧλΠϜ Ͱ૬ஊग़དྷΔͷ͋Γ͕͍ͨ Ͱ͢ 80ˋ ݈߁ҙࣝΛ࣮ײ͍ͯ͠Δ YOJOͷױऀ͞· ͲͪΒͰͳ͍ 12% ຬ͍ͯ͠Δ 87% ෆຬͰ͋Δ 1% ҙࣝ͢ΔΑ͏ʹ ͳͬͨ 77% ͲͪΒͰͳ͍ 14% มΘΒͳ͍ 9% Q.૬ஊͷ͢͠͞ʹຬͰ͔͢ʁ Q.݈߁ҙࣝมԽ͠·͔ͨ͠ʁ ग़యɿPharmaXʮYOJOༀہʹର͢ΔϢʔβʔධՁͷௐࠪʯ20228݄
ʢCʣPharmaX Inc. 2022 All Rights Reserve 23 ͍͞͝ʹ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 24 ͍͞͝ʹ ϦϞʔτༀࡎࢣͷීٴʹ͚ͯ ղېʹͬͯϦϞʔτༀࡎࢣͷ׆༂ͱༀہͷ͔͔Γ͚ͭػೳͷॆ࣮͕ظ͞ΕΔɻҰํͰɺༀہۀʹ
ϦϞʔτༀࡎࢣΛ׆༻͢ΔϊϋΛ࣋ͭاۀݶఆతɻ PharmaXͰɺༀࡎࢣͷϦϞʔτϫʔΫʹΑͬͯױऀ͞·ͷஸ ೡͳ݈߁αϙʔτͱಇ͖͍͢ڥͷཱ྆Λ࣮ݱ ϦϞʔτϫʔΫʹΑΔશࠃ9ສਓͷજࡏༀࡎࢣͷ׆༂͕ༀࡎࢣ ͷ͔͔Γ͚ͭԽͷ伴 ɹɾϦϞʔτༀࡎࢣղېʹΑͬͯɺϦϞʔτༀࡎࢣͷ׆༂͕ظ͞ΕΔ ҰํͰɺༀہۀʹϦϞʔτༀࡎࢣΛ׆༻͢ΔϊϋΛ ࣋ͭاۀݶఆత 1 2 3
ʢCʣPharmaX Inc. 2022 All Rights Reserve 25 ͍͞͝ʹ ⁋ ༟հ
ॱఱಊେֶҩֶ෦ଔۀɻ ϔϧεέΞܥاۀʹͯࣄۀ։ൃΠϯλʔϯɻ ॱఱಊҩӃʹͯྟচͱݚڀʹैࣄͨ͠ޙɺ 201812݄ࣾઃཱ ͓͍߹Θͤઌ https://www.pharma-x.co.jp/ PharmaXגࣜձࣾɺױऀ͞·த৺ͷҩྍମݧΛ࣮ݱ͢ΔͨΊʹɺ ༀہྖҬʹ͓͚ΔDXΛਪਐ͍͖ͯ͠·͢ɻ ࣗࣾༀہΛத৺ʹɺϦϞʔτༀࡎࢣͱಠࣗΦϖϨʔγϣϯγεςϜΛߏங͠ɺ࣍ੈܕͷʮ͔͔Γ͚ͭΦϯϥΠϯༀ ہʯΛఏڙ͓ͯ͠Γ·͢ɻༀہྖҬʹ͓͚ΔDXࣄྫʹ͍ͭͯ͝հͰ͖Δ΄͔ɺॊೈʹύʔτφʔاۀ͞·ͱऔΓ ΈΛ͍͍͓ͤͯͨͩͯ͞Γ·͢ɻ औࡐґཔ͓Αͼ͓߹ͤ PharmaXגࣜձࣾɹ දऔకɾҩࢣ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 26 ͍͞͝ʹ PharmaXௐࠪ֓ཁ ௐࠪςʔϚɿYOJOༀہʹର͢ΔϢʔβʔධՁͷௐࠪ
ௐࠪରɿYOJOༀہར༻ऀ ௐࠪํ๏ɿWebΞϯέʔτܗࣜͰ࣮ࢪ ༗ޮճɿ221݅ ௐ࣮ࠪࢪɿ2022/07/28ʙ2022/08/03 ௐࠪςʔϚɿༀہۀʹؔ͢Δௐࠪ ௐࠪରɿༀہༀࡎࢣͷ͏ͪʮܦӦऀɺϚωʔδϟʔɺ ཧༀࡎࢣɺҰൠࣾһʯ ௐࠪํ๏ɿΠϯλʔωοτϦαʔν ༗ޮճɿ1000݅ ௐ࣮ࠪࢪɿ2022/08/08ʙ8/12 ௐࠪςʔϚɿϦϞʔτༀࡎࢣͷಇ͖ํʹؔ͢Δௐࠪ ௐࠪରɿYOJOༀہैۀһ ௐࠪํ๏ɿWebΞϯέʔτܗࣜͰ࣮ࢪ ༗ޮճɿ14݅ ௐ࣮ࠪࢪɿ2022/07/28ʙ2022/08/03 ௐࠪςʔϚɿༀہༀࡎࢣͷ৬ܦݧʹؔ͢Δௐࠪ ௐࠪରɿༀہༀࡎࢣ ௐࠪํ๏ɿΠϯλʔωοτϦαʔν ༗ޮճɿ1061݅ ௐ࣮ࠪࢪɿ2022/08/08ʙ8/10